Available resources for the treatment of breast cancer in Mexico

被引：0

作者：

Mohar, Alejandro ^{[1
]}

Bargallo, Enrique ^{[1
]}

Teresa Ramirez, Ma ^{[1
]}

Lara, Fernando ^{[1
]}

Beltran-Ortega, Arturo ^{[1
]}

机构：

[1] Univ Nacl Autonoma Mexico, Inst Nacl Cancerol, Inst Invest Biomed, Unidad Invest Biomed Canc, Mexico City 14080, DF, Mexico

来源：

SALUD PUBLICA DE MEXICO | 2009年 / 51卷

关键词：

breast; cancer; costs; treatment; Mexico; ADJUVANT CHEMOTHERAPY; THERAPY; MARKERS; RISK;

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Objective. Describe the resources for the treatment of breast cancer in Mexico. Methods. Information was obtained from 23 Centros Estatales de Cancer (State Cancer Centers, CEC), two federal hospitals and Cancerologia. This study was performed in Mexico City in August/September of 2008. Results. These 23 centers provide medical care for breast cancer including surgery, chemotherapy and radiotherapy; all of them validated by the Seguro Popular. The costs were defined according to clinical stage and ranged from $27,500.00 pesos for clinical stage 0 to $480,00.00 in the advanced stage. A total of 2 689 women with breast cancer have been treated; only 1% was reported with in situ carcinoma. Conclusions. An adequate medical infrastructure is in place to treat breast cancer in Mexico. The costs are high due to late diagnosis of the disease. Early detection of breast cancer is a high priority for optimal control of this disease in Mexico.

引用

页码：S263 / S269

页数：7

共 27 条

[1] Breast cancer in limited-resource countries: An overview of the breast health global initiative 2005 guidelines
Anderson, BO
Shyyan, R
Eniu, A
Smith, RA
Yip, CH
Bese, NS
Chow, LWC
Masood, S
Ramsey, SD
Carlson, RW
[J]. BREAST JOURNAL, 2006, 12 (01) : S3 - S15
[2] [Anonymous], NCCN Clinical Practice Guidelines in Oncology - Breast Cancer
[3] Effect of screening and adjuvant therapy on mortality from breast cancer
Berry, DA
Cronin, KA
Plevritis, SK
Fryback, DG
Clarke, L
Zelen, M
Mandelblatt, JS
Yakovlev, AY
Habbema, JDF
Feuer, EJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) : 1784 - 1792
[4] BRANDAN ME, 2006, REV I NAL CANC, V1, P147
[5] Breast Cancer in Latin America Results of the Latin American and Caribbean Society of Medical Oncology/Breast Cancer Research Foundation Expert Survey
Cazap, Eduardo
Buzaid, Antonio Carlos
Garbino, Carlos
de la Garza, Jaime
Orlandi, Francisco Javier
Schwartsmann, Gilberto
Vallejos, Carlos
Guercovich, Andres
[J]. CANCER, 2008, 113 (08) : 2359 - 2365
[6] Curado M.P. E., 2007, Cancer Incidence in Five Continents, VIX
[7] New strategies to identify molecular markers predicting chemotherapy activity and toxicity in breast cancer
Di Leo, A.
Claudino, W.
Colangiuli, D.
Bessi, S.
Pestrin, M.
Biganzoli, L.
[J]. ANNALS OF ONCOLOGY, 2007, 18 : 8 - 14
[8] FERLAY J, 2006, CANC INCIDENCE PREVA
[9] Health system reform in Mexico 1 -: Comprehensive reform to improve health system performance in Mexico
Frenk, Julio
Gonzalez-Pier, Eduardo
Gomez-Dantes, Octavio
Lezana, Miguel A.
Knaul, Felicia Marie
[J]. LANCET, 2006, 368 (9546) : 1524 - 1534
[10] Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status
Glass, Andrew G.
Lacey, James V., Jr.
Carreon, Daniel
Hoover, Robert N.
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (15): : 1152 - 1161

← 1 2 3 →